ScienceNews

Science News

Nature Medicine, Published online: 04 November 2026; doi:10.1038/s41591-026-04745-4 In a nonrandomized phase 2 trial, patients with resectable non-small cell lung cancer received perioperative ivonescimab as monotherapy or with chemotherapy, leading to encouraging pathological response rates in both cohorts, and sustained circulating tumor DNA negativity throughout neoadjuvant therapy may be predictive of response. Read More

Science News

In basketball, field-goal percentage tells us how often a player makes a shot. But what about the shots’ difficulty? Let’s use Python and machine learning to separate shot selection from shot making. The post A Good Shooter or Just a Good Shot Selector? Using Python to Find Out appeared first on Towards Data Science. Read …